UBS maintained Johnson & Johnson (NYSE:JNJ) at Buy with a $180 per share price target on Friday in its analyst day preview note. The firm said it expects the company to reiterate...
Johnson & Johnson (NYSE:JNJ) MedTech, the company’s medical device business, announced today it finalized the acquisition of Laminar, a private medical device company specializing...
Berkshire Hathaway (NYSE:BRKa), led by renowned investor Warren Buffett, has made significant changes to its stock portfolio, as revealed in its third-quarter earnings report. The...
NEW YORK - Bristol Myers (NYSE:BMY) Squibb Co. (NYSE:BMY) experienced a downturn on Thursday, ending a two-day streak of gains as its shares dropped 1.42% to close at $50.84. The...
The Greek Development Ministry has imposed fines on the local subsidiaries of two major U.S. firms, Johnson & Johnson (NYSE:JNJ) Hellas and Colgate-Palmolive (NYSE:CL) Hellas. The...
By Suzanne McGee (Reuters) - GMO LLC, the asset management firm co-founded by veteran investor Jeremy Grantham, will launch its first exchange-traded fund (ETF) on Wednesday. The...
Johnson & Johnson (NYSE:JNJ)'s MedTech unit is planning to seek FDA clearance for its Ottava robotic surgical system in 2024, following delays caused by technical issues and...